PROCEPT BioRobotics

$36.89 0.00% ($0.00)

Get ready to invest

About PROCEPT BioRobotics

PROCEPT BioRobotics Corporation is a United States-based surgical robotics company. The Company enables patient care by developing transformative solutions in urology. The Company has developed Aquablation therapy for the treatment of benign prostatic hyperplasia (BPH). It has developed a surgical robot, Aquabeam that provides autonomous tissue removal from enlarged prostate to treat BPH. Aquabeam provides multi-dimensional imaging, personalized treatment planning, and heat-free waterjet with autonomous robotic execution.

Popular Stocks	Price	Change
Nu Holdings NU	$4.33 13.35%	13.35%
Annaly NLY	$6.27 1.42%	1.42%
AMD AMD	$96.67 0.41%	0.41%
Nvidia NVDA	$171.24 1.1%	1.1%
SoFi Technologies, Inc. SOFI	$7.75 7.19%	7.19%
Ford F	$12.85 0.55%	0.55%
Apple AAPL	$137.35 2.46%	2.46%
Cisco CSCO	$41.72 13.73%	13.73%
Grab Holdings inc. GRAB	$3.14 24.11%	24.11%
NIO NIO	$16.66 5.24%	5.24%